BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200527T130000
DTEND;TZID=America/Vancouver:20200527T150000
DTSTAMP:20260413T042103
CREATED:20200417T173219Z
LAST-MODIFIED:20200417T173322Z
UID:8751-1590584400-1590591600@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series-5/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200527T130000
DTEND;TZID=America/Vancouver:20200527T150000
DTSTAMP:20260413T042103
CREATED:20200417T173219Z
LAST-MODIFIED:20200417T173219Z
UID:27464-1590584400-1590591600@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series-5-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T080000
DTEND;TZID=America/Vancouver:20200529T170000
DTSTAMP:20260413T042103
CREATED:20200529T191404Z
LAST-MODIFIED:20200529T191404Z
UID:9251-1590739200-1590771600@scienceinboston.com
SUMMARY:Immuno-Oncology 2020
DESCRIPTION:abRoots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on June 3\, 2020. Immuno-oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics. Learn from our experts how immunotherapies can work alone\, together\, or in combination with other treatments to fight cancer. \nThis years event will include the following tracks and topics: \nLatest Trends in Immuno-Oncology \nImmunotherapeutic Modalities \n\nCurrent Opportunities and Challenges\nEmerging Targets for Novel Immuno-Oncology Therapy\n\nDevelopment and Clinical Applications of Cancer Immunotherapies \nRecent breakthroughs in immuno-oncology research translate into a paradigm shift with regards to attacking advancing cancer. The benefits of immuno-oncology have resulted in long-lasting tumor regression where surgery\, radiotherapy\, chemotherapy\, and targeted therapy proved less effective. \nOur virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions. \nLike the 2019 conference\, this event will be produced on our robust platform\, allowing you to watch\, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system\, you can now move around the entire event\, earning points for a chance to win one of LabRoots’ most popular T-shirts. \nall for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary\, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Immuno-Oncology Virtual Event. Submission is free. Submit your abstract here. \nContinuing Education\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event\, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits. \nUse #LRimmuno to follow the conversation!
URL:https://scienceinboston.com/event/immuno-oncology-2020/
LOCATION:MA
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Labroots-immunooncology-2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T080000
DTEND;TZID=America/Vancouver:20200529T170000
DTSTAMP:20260413T042103
CREATED:20200529T191404Z
LAST-MODIFIED:20200529T191404Z
UID:27502-1590739200-1590771600@scienceinboston.com
SUMMARY:Immuno-Oncology 2020
DESCRIPTION:abRoots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on June 3\, 2020. Immuno-oncology is considered by some to be one of the most promising areas of research in the world of anti-cancer therapeutics. Learn from our experts how immunotherapies can work alone\, together\, or in combination with other treatments to fight cancer. \nThis years event will include the following tracks and topics: \nLatest Trends in Immuno-Oncology \nImmunotherapeutic Modalities \n\nCurrent Opportunities and Challenges\nEmerging Targets for Novel Immuno-Oncology Therapy\n\nDevelopment and Clinical Applications of Cancer Immunotherapies \nRecent breakthroughs in immuno-oncology research translate into a paradigm shift with regards to attacking advancing cancer. The benefits of immuno-oncology have resulted in long-lasting tumor regression where surgery\, radiotherapy\, chemotherapy\, and targeted therapy proved less effective. \nOur virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions. \nLike the 2019 conference\, this event will be produced on our robust platform\, allowing you to watch\, learn and connect seamlessly across all desktop or mobile devices. Equipped with gamification and point system\, you can now move around the entire event\, earning points for a chance to win one of LabRoots’ most popular T-shirts. \nall for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary\, and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Immuno-Oncology Virtual Event. Submission is free. Submit your abstract here. \nContinuing Education\nLabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event\, you can earn 1 Continuing Education credit per presentation for a maximum of 30 credits. \nUse #LRimmuno to follow the conversation!
URL:https://scienceinboston.com/event/immuno-oncology-2020-2/
LOCATION:MA
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Labroots-immunooncology-2020.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T080000
DTEND;TZID=America/Vancouver:20200531T170000
DTSTAMP:20260413T042103
CREATED:20200508T225636Z
LAST-MODIFIED:20200508T225636Z
UID:8993-1590739200-1590944400@scienceinboston.com
SUMMARY:American Society of Clinical Oncology Virtual Meeting
DESCRIPTION:Join oncology professionals from around the world for the ASCO20 Virtual Scientific Program to see and hear the brightest minds in oncology presenting state-of-the-art treatment modalities and new therapies. The virtual meeting\, to be held Friday\, May 29\, through Sunday\, May 31\, will provide an engaging lineup of scheduled and on-demand scientific content offering the opportunity to learn and collaborate across a variety of approaches\, disciplines\, and specialties. \nWhile registration is required for all attendees\, the ASCO20 Virtual Scientific Program meeting fees will be discounted for non-members and waived completely for ASCO members. Registration will open in late April\, and attendees of the ASCO20 Virtual Scientific Program will also receive access to the ASCO20 Virtual Education Program\, to be held in August\, at no additional charge. \nWe have planned an exciting meeting and look forward to welcoming you virtually. On Friday May 29\, all oral\, poster\, and poster discussion presentations\, as well as track-based Clinical Science Symposia\, will be available online. Over the weekend\, we will host scheduled events\, including the Opening Session featuring the Presidential Address by Howard A. “Skip” Burris III\, MD and Guest Speaker Address by David Fajgenbaum\, MD; the Plenary Session; cross-cutting Clinical Science Symposia; and track-specific highlight sessions featuring the top science and highest impact results in each area. Participants will be eligible to receive CME\, MOC\, and CE credit. \nASCO20 Virtual Scientific Program Schedule: \n\nWednesday\, May 13: The majority of abstracts accepted for publication at the virtual meeting and for online publication will be released on schedule at 5:00 pm ET.\nFriday\, May 29: Oral\, poster\, and poster discussion sessions\, as well as track-based Clinical Science Symposia\, will be available on demand. Registrants will have exclusive access to hundreds of video and slide presentations\, as well as discussant commentary for 180 days.\nSaturday\, May 30 (All sessions to be hosted in ET)\n\n9:30 am: Opening Session with keynote address from ASCO President Howard A. “Skip” Burris III\, MD and Guest Speaker Address by David Fajgenbaum\, MD\n10:30 am: Highlights Sessions: Breast Cancer; Head and Neck Cancer\n11:00 am: Highlights Sessions: Gastrointestinal Cancers; Central Nervous System Tumors\n11:30 am: Highlights Sessions: Hematological Malignancies; Gynecological Cancers\n1:00 pm: Clinical Science Symposium: Harnessing Immunotherapy with Novel Approaches Beyond Checkpoint Inhibitors\n2:30 pm: Highlights Sessions: Cancer Prevention\, Risk Reduction\, and Genetics; Symptoms and Survivorship\n3:30 pm: Clinical Science Symposium: Redefining Cancer of Unknown Primary: Is Genomics the Answer?\n\n\nSunday\, May 31 (All sessions to be hosted in ET)\n\n9:30 am: Highlights Sessions: Melanoma; Health Services Research and Quality Improvement\n10:00 am: Highlights Sessions: Lung Cancer; Pediatric Oncology\n10:30 am: Clinical Science Symposium: Drug Development for Rare Mutations: The Opportunity to Unite and Conquer\n1:00 pm: Plenary Session\n3:30 pm: Highlights Sessions: Genitourinary Cancers; Sarcoma\n4:00 pm: Highlights Sessions: Developmental Therapeutics; Care Delivery and Regulatory Policy\n\n\n\nWatch for the full digital program – available on April 29th. \nIn addition\, we will be hosting the ASCO20 Virtual Education Program in August 2020. Watch for more details in the coming weeks. \nPlease continue to check our regularly updated FAQs for additional details\, and follow @ASCO on Twitter for real-time updates. Should you have any questions\, please contact us at meetings@asco.org.
URL:https://scienceinboston.com/event/american-society-of-clinical-oncology-virtual-meeting/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T080000
DTEND;TZID=America/Vancouver:20200531T170000
DTSTAMP:20260413T042103
CREATED:20200508T225636Z
LAST-MODIFIED:20200508T225636Z
UID:27482-1590739200-1590944400@scienceinboston.com
SUMMARY:American Society of Clinical Oncology Virtual Meeting
DESCRIPTION:Join oncology professionals from around the world for the ASCO20 Virtual Scientific Program to see and hear the brightest minds in oncology presenting state-of-the-art treatment modalities and new therapies. The virtual meeting\, to be held Friday\, May 29\, through Sunday\, May 31\, will provide an engaging lineup of scheduled and on-demand scientific content offering the opportunity to learn and collaborate across a variety of approaches\, disciplines\, and specialties. \nWhile registration is required for all attendees\, the ASCO20 Virtual Scientific Program meeting fees will be discounted for non-members and waived completely for ASCO members. Registration will open in late April\, and attendees of the ASCO20 Virtual Scientific Program will also receive access to the ASCO20 Virtual Education Program\, to be held in August\, at no additional charge. \nWe have planned an exciting meeting and look forward to welcoming you virtually. On Friday May 29\, all oral\, poster\, and poster discussion presentations\, as well as track-based Clinical Science Symposia\, will be available online. Over the weekend\, we will host scheduled events\, including the Opening Session featuring the Presidential Address by Howard A. “Skip” Burris III\, MD and Guest Speaker Address by David Fajgenbaum\, MD; the Plenary Session; cross-cutting Clinical Science Symposia; and track-specific highlight sessions featuring the top science and highest impact results in each area. Participants will be eligible to receive CME\, MOC\, and CE credit. \nASCO20 Virtual Scientific Program Schedule: \n\nWednesday\, May 13: The majority of abstracts accepted for publication at the virtual meeting and for online publication will be released on schedule at 5:00 pm ET.\nFriday\, May 29: Oral\, poster\, and poster discussion sessions\, as well as track-based Clinical Science Symposia\, will be available on demand. Registrants will have exclusive access to hundreds of video and slide presentations\, as well as discussant commentary for 180 days.\nSaturday\, May 30 (All sessions to be hosted in ET)\n\n9:30 am: Opening Session with keynote address from ASCO President Howard A. “Skip” Burris III\, MD and Guest Speaker Address by David Fajgenbaum\, MD\n10:30 am: Highlights Sessions: Breast Cancer; Head and Neck Cancer\n11:00 am: Highlights Sessions: Gastrointestinal Cancers; Central Nervous System Tumors\n11:30 am: Highlights Sessions: Hematological Malignancies; Gynecological Cancers\n1:00 pm: Clinical Science Symposium: Harnessing Immunotherapy with Novel Approaches Beyond Checkpoint Inhibitors\n2:30 pm: Highlights Sessions: Cancer Prevention\, Risk Reduction\, and Genetics; Symptoms and Survivorship\n3:30 pm: Clinical Science Symposium: Redefining Cancer of Unknown Primary: Is Genomics the Answer?\n\n\nSunday\, May 31 (All sessions to be hosted in ET)\n\n9:30 am: Highlights Sessions: Melanoma; Health Services Research and Quality Improvement\n10:00 am: Highlights Sessions: Lung Cancer; Pediatric Oncology\n10:30 am: Clinical Science Symposium: Drug Development for Rare Mutations: The Opportunity to Unite and Conquer\n1:00 pm: Plenary Session\n3:30 pm: Highlights Sessions: Genitourinary Cancers; Sarcoma\n4:00 pm: Highlights Sessions: Developmental Therapeutics; Care Delivery and Regulatory Policy\n\n\n\nWatch for the full digital program – available on April 29th. \nIn addition\, we will be hosting the ASCO20 Virtual Education Program in August 2020. Watch for more details in the coming weeks. \nPlease continue to check our regularly updated FAQs for additional details\, and follow @ASCO on Twitter for real-time updates. Should you have any questions\, please contact us at meetings@asco.org.
URL:https://scienceinboston.com/event/american-society-of-clinical-oncology-virtual-meeting-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T110000
DTEND;TZID=America/Vancouver:20200529T130000
DTSTAMP:20260413T042103
CREATED:20200527T205753Z
LAST-MODIFIED:20200527T205753Z
UID:9240-1590750000-1590757200@scienceinboston.com
SUMMARY:Healthcare Businesswomen's Association
DESCRIPTION:The HBA is proud to introduce Illuminate 2020\, a bold new signature event inspired by our commitment to recognizing our industry and its amazing leaders as we convene our community virtually during this challenging time. Thanks to our generous sponsors\, complimentary registration is available for members and employees of corporate partners. \nThis two-hour program will include three significant panel discussions featuring conversations with accomplished and inspiring figures in healthcare and the life sciences who will discuss innovation and breakthroughs\, agility in action\, effective collaboration and game-changing milestones which fuel our pride in our industry. \nSession 1: Breaking Through With Science \n\n(Moderator) Shannon Resetich\, global franchise head\, rare diseases\, Sanofi Genzyme\nDr. Deborah Dunsire\, CEO\, Lundbeck\nHBA Honorable Mentor Dr. Rod MacKenzie\, chief development officer and EVP\, Pfizer Global Product Development\nChristi Shaw\, CEO\, Kite\, a Gilead company\n\nSession 2: The Art of Agility \n\n(Session opener) Shideh Sedgh Bina\, founding partner\, Insigniam\n(Moderator) Pam Cheng\, EVP\, global operations and IT\, AstraZeneca\nDr. Susan C. Nicholson FIDSA\, VP\, women’s health\, Johnson & Johnson\nKristin Pothier\, global and national healthcare and life sciences strategy leader\, deal advisory and strategy\, KPMG\nHBA STAR Susan Torroella\, CEO and president\, ArmadaHealth\n\nSession 3: Patient Advocacy Innovators \n\n(Session opener) Julie Gerberding\, EVP and chief patient officer\, communications\, global policy\, and population health\, Merck\n(Moderator) Jhaymee Tynan\, assistant VP\, integration\, Atrium Health\nChris Boerner\, chief commercialization officer and EVP\, Bristol-Myers Squibb\nHBA Woman of the Year Dr. Sandra Horning\, former chief medical officer and head of global product development\, Genentech and Roche\nGeorgia Lehoczky\, regional healthcare director\, Walgreens\n\nEach panel includes HBA honorees with discussions about how these extraordinary leaders leverage business opportunities and personal experience to accelerate the development and delivery of healthcare globally. \nThere will be live chat opportunities with select panelists\, additional industry leaders and other attendees\, as well as access to event sponsors who remain committed to supporting the HBA’s mission of furthering the advancement and impact of women in the business of healthcare. \nParticipants will leave informed\, enlightened\, inspired\, more globally connected and proud(er) of our industry and those leading it.
URL:https://scienceinboston.com/event/healthcare-businesswomens-association/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Illuminate-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T110000
DTEND;TZID=America/Vancouver:20200529T130000
DTSTAMP:20260413T042103
CREATED:20200527T205753Z
LAST-MODIFIED:20200527T205753Z
UID:27501-1590750000-1590757200@scienceinboston.com
SUMMARY:Healthcare Businesswomen's Association
DESCRIPTION:The HBA is proud to introduce Illuminate 2020\, a bold new signature event inspired by our commitment to recognizing our industry and its amazing leaders as we convene our community virtually during this challenging time. Thanks to our generous sponsors\, complimentary registration is available for members and employees of corporate partners. \nThis two-hour program will include three significant panel discussions featuring conversations with accomplished and inspiring figures in healthcare and the life sciences who will discuss innovation and breakthroughs\, agility in action\, effective collaboration and game-changing milestones which fuel our pride in our industry. \nSession 1: Breaking Through With Science \n\n(Moderator) Shannon Resetich\, global franchise head\, rare diseases\, Sanofi Genzyme\nDr. Deborah Dunsire\, CEO\, Lundbeck\nHBA Honorable Mentor Dr. Rod MacKenzie\, chief development officer and EVP\, Pfizer Global Product Development\nChristi Shaw\, CEO\, Kite\, a Gilead company\n\nSession 2: The Art of Agility \n\n(Session opener) Shideh Sedgh Bina\, founding partner\, Insigniam\n(Moderator) Pam Cheng\, EVP\, global operations and IT\, AstraZeneca\nDr. Susan C. Nicholson FIDSA\, VP\, women’s health\, Johnson & Johnson\nKristin Pothier\, global and national healthcare and life sciences strategy leader\, deal advisory and strategy\, KPMG\nHBA STAR Susan Torroella\, CEO and president\, ArmadaHealth\n\nSession 3: Patient Advocacy Innovators \n\n(Session opener) Julie Gerberding\, EVP and chief patient officer\, communications\, global policy\, and population health\, Merck\n(Moderator) Jhaymee Tynan\, assistant VP\, integration\, Atrium Health\nChris Boerner\, chief commercialization officer and EVP\, Bristol-Myers Squibb\nHBA Woman of the Year Dr. Sandra Horning\, former chief medical officer and head of global product development\, Genentech and Roche\nGeorgia Lehoczky\, regional healthcare director\, Walgreens\n\nEach panel includes HBA honorees with discussions about how these extraordinary leaders leverage business opportunities and personal experience to accelerate the development and delivery of healthcare globally. \nThere will be live chat opportunities with select panelists\, additional industry leaders and other attendees\, as well as access to event sponsors who remain committed to supporting the HBA’s mission of furthering the advancement and impact of women in the business of healthcare. \nParticipants will leave informed\, enlightened\, inspired\, more globally connected and proud(er) of our industry and those leading it.
URL:https://scienceinboston.com/event/healthcare-businesswomens-association-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Illuminate-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T120000
DTEND;TZID=America/Vancouver:20200529T130000
DTSTAMP:20260413T042103
CREATED:20200526T173646Z
LAST-MODIFIED:20200526T174350Z
UID:9186-1590753600-1590757200@scienceinboston.com
SUMMARY:DF/HCC Connect:Science Seminar: Ashani Weeraratna
DESCRIPTION:The DF/HCC Connect:Science seminar series offers remote participation through Zoom (create an account here) to pull our community of faculty\, trainees\, and lab staff together during this difficult time and it promotes engagement during these next several weeks. We plan to involve speakers who are leaders in cancer biology\, immune oncology and other fields from across the world. Thank you to the Leukemia & Lymphoma Society for partnering with DF/HCC in this effort\, which will be broadcast to researchers around the globe and recorded for subsequent viewing. \nThe series will begin on March 23 and be held every Monday\, Tuesday\, Thursday and Friday. All talks will be begin at 12 PM EST. \nFor more information about this seminar series\, email: dfhcc@partners.org
URL:https://scienceinboston.com/event/df-hcc-connectscience-seminar-ashani-weeraratna/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/DF-HCC-Connect-Science-seminar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200529T120000
DTEND;TZID=America/Vancouver:20200529T130000
DTSTAMP:20260413T042103
CREATED:20200526T173646Z
LAST-MODIFIED:20200526T173646Z
UID:27494-1590753600-1590757200@scienceinboston.com
SUMMARY:DF/HCC Connect:Science Seminar: Ashani Weeraratna
DESCRIPTION:The DF/HCC Connect:Science seminar series offers remote participation through Zoom (create an account here) to pull our community of faculty\, trainees\, and lab staff together during this difficult time and it promotes engagement during these next several weeks. We plan to involve speakers who are leaders in cancer biology\, immune oncology and other fields from across the world. Thank you to the Leukemia & Lymphoma Society for partnering with DF/HCC in this effort\, which will be broadcast to researchers around the globe and recorded for subsequent viewing. \nThe series will begin on March 23 and be held every Monday\, Tuesday\, Thursday and Friday. All talks will be begin at 12 PM EST. \nFor more information about this seminar series\, email: dfhcc@partners.org
URL:https://scienceinboston.com/event/df-hcc-connectscience-seminar-ashani-weeraratna-2/
LOCATION:Online
ATTACH;FMTTYPE=image/png:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/DF-HCC-Connect-Science-seminar.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200602T110000
DTEND;TZID=America/Vancouver:20200602T113000
DTSTAMP:20260413T042103
CREATED:20200522T175719Z
LAST-MODIFIED:20200522T175719Z
UID:9142-1591095600-1591097400@scienceinboston.com
SUMMARY:MassBio Town Hall W/ Special Guest From HelixNano – How To Develop A Universal Coronavirus Vaccine
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a weekly virtual Town Hall for members\, taking place every Tuesday at 11am. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nFor this Town Hall\, Bob will be joined by special guest Hannu Rajaniemi\, Co-founder and CEO of HelixNano\, who will share insights around his work developing a vaccine for not just COVID-19\, but future coronavirus mutations. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. This event is for members-only. \nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-w-special-guest-from-helixnano-how-to-develop-a-universal-coronavirus-vaccine/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200602T110000
DTEND;TZID=America/Vancouver:20200602T113000
DTSTAMP:20260413T042103
CREATED:20200522T175719Z
LAST-MODIFIED:20200522T175719Z
UID:27491-1591095600-1591097400@scienceinboston.com
SUMMARY:MassBio Town Hall W/ Special Guest From HelixNano – How To Develop A Universal Coronavirus Vaccine
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a weekly virtual Town Hall for members\, taking place every Tuesday at 11am. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nFor this Town Hall\, Bob will be joined by special guest Hannu Rajaniemi\, Co-founder and CEO of HelixNano\, who will share insights around his work developing a vaccine for not just COVID-19\, but future coronavirus mutations. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. This event is for members-only. \nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-w-special-guest-from-helixnano-how-to-develop-a-universal-coronavirus-vaccine-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200602T130000
DTEND;TZID=America/Vancouver:20200602T140000
DTSTAMP:20260413T042103
CREATED:20200527T172537Z
LAST-MODIFIED:20200527T172722Z
UID:9202-1591102800-1591106400@scienceinboston.com
SUMMARY:STAT+ Conversations: A Conversation with the Chan Zuckerberg Initiative
DESCRIPTION:STAT+ Conversations: A weekly broadcast where you’ll hear from STAT reporters\, and leaders in health and medicine\n\nSpeakers: \n\nPriscilla Chan\, M.D.\, co-founder & co-CEO of the Chan Zuckerberg Initiative\nCori Bargmann\, Ph.D.\, head of science at the Chan Zuckerberg Initiative\nRebecca Robbins\, San Francisco correspondent\, STAT
URL:https://scienceinboston.com/event/stat-conversations-a-conversation-with-the-chan-zuckerberg-initiative/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200602T130000
DTEND;TZID=America/Vancouver:20200602T140000
DTSTAMP:20260413T042103
CREATED:20200527T172537Z
LAST-MODIFIED:20200527T172537Z
UID:27496-1591102800-1591106400@scienceinboston.com
SUMMARY:STAT+ Conversations: A Conversation with the Chan Zuckerberg Initiative
DESCRIPTION:STAT+ Conversations: A weekly broadcast where you’ll hear from STAT reporters\, and leaders in health and medicine\n\nSpeakers: \n\nPriscilla Chan\, M.D.\, co-founder & co-CEO of the Chan Zuckerberg Initiative\nCori Bargmann\, Ph.D.\, head of science at the Chan Zuckerberg Initiative\nRebecca Robbins\, San Francisco correspondent\, STAT
URL:https://scienceinboston.com/event/stat-conversations-a-conversation-with-the-chan-zuckerberg-initiative-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200603T110000
DTEND;TZID=America/Vancouver:20200603T130000
DTSTAMP:20260413T042103
CREATED:20200417T173300Z
LAST-MODIFIED:20200417T173300Z
UID:8753-1591182000-1591189200@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series-6/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200603T110000
DTEND;TZID=America/Vancouver:20200603T130000
DTSTAMP:20260413T042103
CREATED:20200417T173300Z
LAST-MODIFIED:20200417T173300Z
UID:27465-1591182000-1591189200@scienceinboston.com
SUMMARY:2020 Virtual Grant Writing Series
DESCRIPTION:Are you working on a grant proposal and want to make your application stand out? \nJoin us for the 2020 Virtual Grant Writing Series\, offered by Professional Development and Postdoctoral Affairs. This 6-week series focuses on how to clearly and concisely express the significance\, approach\, and innovation of your study. After learning about effective writing strategies and grant mechanics\, you’ll have dedicated writing time and receive peer feedback on your proposal. \nAll disciplines are welcome to attend. You are encouraged to attend all 6 sessions! \nLocation: Zoom \nDates: \n\nWednesday\, April 29th 11AM – 1PM\nWednesday\, May 6th 11AM – 1PM\nWednesday\, May 13th 11AM – 1PM\nWednesday\, May 20th 11AM – 1PM\nWednesday\, May 27th 1PM – 3PM (note time difference)\nWednesday\, June 3rd 11AM – 1PM
URL:https://scienceinboston.com/event/2020-virtual-grant-writing-series-6-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200604T150000
DTEND;TZID=America/Vancouver:20200604T171500
DTSTAMP:20260413T042103
CREATED:20200527T205005Z
LAST-MODIFIED:20200527T205005Z
UID:9235-1591282800-1591290900@scienceinboston.com
SUMMARY:Career Panel: Planning for Your Career During a Crisis
DESCRIPTION:A great group of panelists will describe their own career journey\, what industry hiring practices currently look like in their roles\, and describe how their companies have fared in past economic downturns. \nPanelists include: \n• Jane Owens\, PhD – Senior Director and Head of Neuromuscular Research\, Rare Disease Research Unit\, Pfizer \n• Neema Yazdani – Scientific Program Manager\, Taconic Biosciences \n• Heath D. Schmidt – Associate Professor of Psychiatry\, University of Pennsylvania \n• Dara Lee Luca – Senior Researcher\, Mathematica \n• Eoin Cannon – Chief Speechwriter\, City of Boston \n• Don McDaniel – VP of R&D\, Energetiq\, a Hamamatsu company \n• Lisa Peterson – Principal Engineer and President\, Aftan Engineering\, LLC \n\n\n\n\nLOCATION:\nVirtual Event Register Online URL link below\nREGISTRATION:\nhttps://tinyurl.com/BU6420
URL:https://scienceinboston.com/event/career-panel-planning-for-your-career-during-a-crisis/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200604T150000
DTEND;TZID=America/Vancouver:20200604T171500
DTSTAMP:20260413T042103
CREATED:20200527T205005Z
LAST-MODIFIED:20200527T205005Z
UID:27499-1591282800-1591290900@scienceinboston.com
SUMMARY:Career Panel: Planning for Your Career During a Crisis
DESCRIPTION:A great group of panelists will describe their own career journey\, what industry hiring practices currently look like in their roles\, and describe how their companies have fared in past economic downturns. \nPanelists include: \n• Jane Owens\, PhD – Senior Director and Head of Neuromuscular Research\, Rare Disease Research Unit\, Pfizer \n• Neema Yazdani – Scientific Program Manager\, Taconic Biosciences \n• Heath D. Schmidt – Associate Professor of Psychiatry\, University of Pennsylvania \n• Dara Lee Luca – Senior Researcher\, Mathematica \n• Eoin Cannon – Chief Speechwriter\, City of Boston \n• Don McDaniel – VP of R&D\, Energetiq\, a Hamamatsu company \n• Lisa Peterson – Principal Engineer and President\, Aftan Engineering\, LLC \n\n\n\n\nLOCATION:\nVirtual Event Register Online URL link below\nREGISTRATION:\nhttps://tinyurl.com/BU6420
URL:https://scienceinboston.com/event/career-panel-planning-for-your-career-during-a-crisis-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200604T200000
DTEND;TZID=America/Vancouver:20200604T213000
DTSTAMP:20260413T042103
CREATED:20200526T173848Z
LAST-MODIFIED:20200526T173848Z
UID:9190-1591300800-1591306200@scienceinboston.com
SUMMARY:Virtual Café Scientifique | Science Behind Combating COVID-19
DESCRIPTION:Join Dr. Tal Raveh\, a researcher in the area of immunotherapy for cancer and infectious diseases at Stanford Institute for Stem Cell Biology and Regenerative Medicine\, who has prepared a lecture to explain the efforts done by the scientific community to develop ways to fight and defeat COVID19/the pandemic. \nWith the majority of the reporting in the media done by journalists\, there has been an abundance of information distributed about the extent of the pandemic\, severity of viral spreading\, identifying symptoms\, testing practicalities the situation in hospitals and about the public policy and regulations and their impact on everyday life and on the economy. Among all of these topics\, we felt that it is important to emphasize the voice of science\, communicated by scientists directly. \nDuring the presentation\, Tal will dive into the basic biology of viral infections and the immune responses that follow. She will explore PCR\, antigen and antibody testing\, the science behind vaccine development\, and some of the current research efforts on therapeutics\, including Remdesivir\, in managing COVID-19! \nThis discussion will provide enough background so people from all fields can understand. There will also be opportunities for questions from the audience via a virtual chat. \nAgenda \n\n5:00-5:15pm: Welcome\n5:15-6:00pm: Presentation\n6:00-6:30pm: Q&A\n\nTal holds a B.S. in Life Science from Tel Aviv University\, with a focus on microbiology. She then pursued a M.Sc. at the department of molecular genetics at the Weizmann Institute in Israel\, and studied commonalities between anti-viral and anti-cancer responses to Interferons\, followed by a Ph.D. focused on mechanism underlying cellular suicide and their relationship to cancer formation. She then moved to the US and joined Stanford first as a postdoctoral fellow\, then a researcher\, became interested in cancer immunotherapy and was involved in the development of anti-CD47 as a new anti-cancer immunotherapy. Tal directed a brain cancer research team\, and conducted studies using xenograft model with brain tumor samples from patients\, to test that anti-CD47\, a new anti-cancer immunotherapy developed in Irv Weissman’s lab. In those animal models she showed that this new immunotherapy has efficacy for treating both adult and pediatric brain tumors pre-clinical trials. \nIn 2012 she founded a consulting company\, “Science Works”\, and provided scientific consulting for discovery-stage research\, including program development\, proposals building\, grant applications\, publications\, mostly in the field of stem cell biology. She then was recruited back Stanford to work with prof Weissman\, the director of the Institute for Stem Cell Biology and Regenerative Medicine. \nAs a Scientist driven to improve public education\, she wrote a few pieces about COVID19 for her family\, friends\, community and received an overwhelmingly grateful response\, indicating that people are thirsty for scientific background and fact-based data that can give them a sense of clarity in these trying times.
URL:https://scienceinboston.com/event/virtual-cafe-scientifique-science-behind-combating-covid-19/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Virtual-Café-Scientifique-June-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200604T200000
DTEND;TZID=America/Vancouver:20200604T213000
DTSTAMP:20260413T042103
CREATED:20200526T173848Z
LAST-MODIFIED:20200526T173848Z
UID:27495-1591300800-1591306200@scienceinboston.com
SUMMARY:Virtual Café Scientifique | Science Behind Combating COVID-19
DESCRIPTION:Join Dr. Tal Raveh\, a researcher in the area of immunotherapy for cancer and infectious diseases at Stanford Institute for Stem Cell Biology and Regenerative Medicine\, who has prepared a lecture to explain the efforts done by the scientific community to develop ways to fight and defeat COVID19/the pandemic. \nWith the majority of the reporting in the media done by journalists\, there has been an abundance of information distributed about the extent of the pandemic\, severity of viral spreading\, identifying symptoms\, testing practicalities the situation in hospitals and about the public policy and regulations and their impact on everyday life and on the economy. Among all of these topics\, we felt that it is important to emphasize the voice of science\, communicated by scientists directly. \nDuring the presentation\, Tal will dive into the basic biology of viral infections and the immune responses that follow. She will explore PCR\, antigen and antibody testing\, the science behind vaccine development\, and some of the current research efforts on therapeutics\, including Remdesivir\, in managing COVID-19! \nThis discussion will provide enough background so people from all fields can understand. There will also be opportunities for questions from the audience via a virtual chat. \nAgenda \n\n5:00-5:15pm: Welcome\n5:15-6:00pm: Presentation\n6:00-6:30pm: Q&A\n\nTal holds a B.S. in Life Science from Tel Aviv University\, with a focus on microbiology. She then pursued a M.Sc. at the department of molecular genetics at the Weizmann Institute in Israel\, and studied commonalities between anti-viral and anti-cancer responses to Interferons\, followed by a Ph.D. focused on mechanism underlying cellular suicide and their relationship to cancer formation. She then moved to the US and joined Stanford first as a postdoctoral fellow\, then a researcher\, became interested in cancer immunotherapy and was involved in the development of anti-CD47 as a new anti-cancer immunotherapy. Tal directed a brain cancer research team\, and conducted studies using xenograft model with brain tumor samples from patients\, to test that anti-CD47\, a new anti-cancer immunotherapy developed in Irv Weissman’s lab. In those animal models she showed that this new immunotherapy has efficacy for treating both adult and pediatric brain tumors pre-clinical trials. \nIn 2012 she founded a consulting company\, “Science Works”\, and provided scientific consulting for discovery-stage research\, including program development\, proposals building\, grant applications\, publications\, mostly in the field of stem cell biology. She then was recruited back Stanford to work with prof Weissman\, the director of the Institute for Stem Cell Biology and Regenerative Medicine. \nAs a Scientist driven to improve public education\, she wrote a few pieces about COVID19 for her family\, friends\, community and received an overwhelmingly grateful response\, indicating that people are thirsty for scientific background and fact-based data that can give them a sense of clarity in these trying times.
URL:https://scienceinboston.com/event/virtual-cafe-scientifique-science-behind-combating-covid-19-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/Virtual-Café-Scientifique-June-4.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200608T080000
DTEND;TZID=America/Vancouver:20200612T170000
DTSTAMP:20260413T042103
CREATED:20200415T154914Z
LAST-MODIFIED:20200415T154914Z
UID:8688-1591603200-1591981200@scienceinboston.com
SUMMARY:BIO Digital
DESCRIPTION:When collaboration is more vital than ever\, you can still rely on BIO to bring the industry together.\n\n\nFor 2020\, the BIO International Convention will transition to a new\, virtual event format\, BIO Digital. This virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering\, educational resources to help drive your business\, and the insights you need to continue critical research and development. \nWe may not be able to gather in person\, but nothing stops innovation.
URL:https://scienceinboston.com/event/bio-digital/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200608T080000
DTEND;TZID=America/Vancouver:20200612T170000
DTSTAMP:20260413T042103
CREATED:20200415T154914Z
LAST-MODIFIED:20200415T154914Z
UID:27450-1591603200-1591981200@scienceinboston.com
SUMMARY:BIO Digital
DESCRIPTION:When collaboration is more vital than ever\, you can still rely on BIO to bring the industry together.\n\n\nFor 2020\, the BIO International Convention will transition to a new\, virtual event format\, BIO Digital. This virtual gathering of the global biotech industry provides access to key partners via BIO One-on-One Partnering\, educational resources to help drive your business\, and the insights you need to continue critical research and development. \nWe may not be able to gather in person\, but nothing stops innovation.
URL:https://scienceinboston.com/event/bio-digital-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T110000
DTEND;TZID=America/Vancouver:20200609T113000
DTSTAMP:20260413T042103
CREATED:20200522T175814Z
LAST-MODIFIED:20200522T175814Z
UID:9144-1591700400-1591702200@scienceinboston.com
SUMMARY:MassBio Town Hall W/ Special Guest Congresswoman Katherine Clark – Spotlight On The Federal Government’s Response To COVID
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a weekly virtual Town Hall for members\, taking place every Tuesday at 11am. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nFor this Town Hall\, Bob will be joined by special guest Congresswoman Katherine Clark (MA-05) who will share insights on the federal government’s work around COVID-19 and how the life sciences industry can continue to support these efforts. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. This event is for members-only. \nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-w-special-guest-congresswoman-katherine-clark-spotlight-on-the-federal-governments-response-to-covid/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T110000
DTEND;TZID=America/Vancouver:20200609T113000
DTSTAMP:20260413T042103
CREATED:20200522T175814Z
LAST-MODIFIED:20200522T175814Z
UID:27492-1591700400-1591702200@scienceinboston.com
SUMMARY:MassBio Town Hall W/ Special Guest Congresswoman Katherine Clark – Spotlight On The Federal Government’s Response To COVID
DESCRIPTION:MassBio’s President & CEO\, Bob Coughlin\, will host a weekly virtual Town Hall for members\, taking place every Tuesday at 11am. This will be an opportunity for our members to ask questions\, hear what MassBio is up to\, and learn more about the state of the industry amidst the COVID-19 pandemic. \nFor this Town Hall\, Bob will be joined by special guest Congresswoman Katherine Clark (MA-05) who will share insights on the federal government’s work around COVID-19 and how the life sciences industry can continue to support these efforts. \nWebinar link will be emailed to participants the day before – you can also access it from the “Live Stream” tab below. This event is for members-only. \nNOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations\, such as captioning.
URL:https://scienceinboston.com/event/massbio-town-hall-w-special-guest-congresswoman-katherine-clark-spotlight-on-the-federal-governments-response-to-covid-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T130000
DTEND;TZID=America/Vancouver:20200609T140000
DTSTAMP:20260413T042103
CREATED:20200527T172636Z
LAST-MODIFIED:20200527T172738Z
UID:9204-1591707600-1591711200@scienceinboston.com
SUMMARY:STAT+ Conversations: A Conversation with Merck on Developing COVID-19 Vaccines and Treatments
DESCRIPTION:STAT+ Conversations: A weekly broadcast where you’ll hear from STAT reporters\, and leaders in health and medicine\nSpeakers: \n\nJulie Gerberding\, executive vice president and chief patient officer\, communications\, global policy\, and population health\, Merck\nHelen Branswell\, senior writer\, infectious disease\, STAT
URL:https://scienceinboston.com/event/stat-conversations-a-conversation-with-merck-on-developing-covid-19-vaccines-and-treatments/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200609T130000
DTEND;TZID=America/Vancouver:20200609T140000
DTSTAMP:20260413T042103
CREATED:20200527T172636Z
LAST-MODIFIED:20200527T172636Z
UID:27497-1591707600-1591711200@scienceinboston.com
SUMMARY:STAT+ Conversations: A Conversation with Merck on Developing COVID-19 Vaccines and Treatments
DESCRIPTION:STAT+ Conversations: A weekly broadcast where you’ll hear from STAT reporters\, and leaders in health and medicine\nSpeakers: \n\nJulie Gerberding\, executive vice president and chief patient officer\, communications\, global policy\, and population health\, Merck\nHelen Branswell\, senior writer\, infectious disease\, STAT
URL:https://scienceinboston.com/event/stat-conversations-a-conversation-with-merck-on-developing-covid-19-vaccines-and-treatments-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260413T042103
CREATED:20200527T204807Z
LAST-MODIFIED:20200527T204807Z
UID:9231-1591876800-1591880400@scienceinboston.com
SUMMARY:Harvard Microbial Sciences Initiative Summer Seminar
DESCRIPTION:We are pleased to announce an MSI virtual seminar series! On the second Thursday of each month this summer\, we’re bringing you a seminar full of interesting microbiology and the interesting microbiologist who makes it happen.\nMark your calendar for the first in the series: on Thursday\, June 11\, 2020 @ 12pm EST\, we’ll hear from Dr. Ronald Oremland. The seminars will be free and open to all\, no registration or sign up required. Faculty\, staff\, postdocs\, graduate students\, undergraduates\, and microbe enthusiasts of any variety are encouraged to attend. The talk will be streamed live on our YouTube channel\, so if you attended the 2020 symposium\, you already know what to do! And if you can’t make it to the live event\, no need to worry – the talk will be recorded and available on the MSI YouTube channel afterward.
URL:https://scienceinboston.com/event/harvard-microbial-sciences-initiative-summer-seminar/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/MSI-virtual-seminar-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260413T042103
CREATED:20200527T204807Z
LAST-MODIFIED:20200527T204807Z
UID:27498-1591876800-1591880400@scienceinboston.com
SUMMARY:Harvard Microbial Sciences Initiative Summer Seminar
DESCRIPTION:We are pleased to announce an MSI virtual seminar series! On the second Thursday of each month this summer\, we’re bringing you a seminar full of interesting microbiology and the interesting microbiologist who makes it happen.\nMark your calendar for the first in the series: on Thursday\, June 11\, 2020 @ 12pm EST\, we’ll hear from Dr. Ronald Oremland. The seminars will be free and open to all\, no registration or sign up required. Faculty\, staff\, postdocs\, graduate students\, undergraduates\, and microbe enthusiasts of any variety are encouraged to attend. The talk will be streamed live on our YouTube channel\, so if you attended the 2020 symposium\, you already know what to do! And if you can’t make it to the live event\, no need to worry – the talk will be recorded and available on the MSI YouTube channel afterward.
URL:https://scienceinboston.com/event/harvard-microbial-sciences-initiative-summer-seminar-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/05/MSI-virtual-seminar-series.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260413T042103
CREATED:20200602T204813Z
LAST-MODIFIED:20200602T204813Z
UID:9310-1591876800-1591880400@scienceinboston.com
SUMMARY:Building Better COVID-19 Tools Together: Using Scalable NGS to Accelerate Science
DESCRIPTION:With the numerous plasmids being shared by the research community for COVID-19 research\, Addgene acted fast to get these reagents available to scientists\, through QC and distribution. Learn about their QC workflows using NGS in an upcoming webinar with co-hosted by Addgene and seqWell. \nJune 11\, 2020\n12pm Eastern/9am Pacific \nSpeakers:\nJoseph Mellor\, Ph.D.\, CEO\, seqWell\nJoanne Kamens\, Ph.D.\, Executive Director\, Addgene \nSign up to join us: https://sambasci.com/seqwell-webinar-building-better-covid-19-tools-together/ \n—— \nAddgene is a nonprofit plasmid repository whose mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials\, research reproducibility\, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide.
URL:https://scienceinboston.com/event/building-better-covid-19-tools-together-using-scalable-ngs-to-accelerate-science/
LOCATION:MA
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/seqwell-webinar-social-01.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20200611T120000
DTEND;TZID=America/Vancouver:20200611T130000
DTSTAMP:20260413T042103
CREATED:20200602T204813Z
LAST-MODIFIED:20200602T204813Z
UID:27504-1591876800-1591880400@scienceinboston.com
SUMMARY:Building Better COVID-19 Tools Together: Using Scalable NGS to Accelerate Science
DESCRIPTION:With the numerous plasmids being shared by the research community for COVID-19 research\, Addgene acted fast to get these reagents available to scientists\, through QC and distribution. Learn about their QC workflows using NGS in an upcoming webinar with co-hosted by Addgene and seqWell. \nJune 11\, 2020\n12pm Eastern/9am Pacific \nSpeakers:\nJoseph Mellor\, Ph.D.\, CEO\, seqWell\nJoanne Kamens\, Ph.D.\, Executive Director\, Addgene \nSign up to join us: https://sambasci.com/seqwell-webinar-building-better-covid-19-tools-together/ \n—— \nAddgene is a nonprofit plasmid repository whose mission is to accelerate research and discovery by improving access to useful research materials and information. Addgene facilitates the sharing of high-quality scientific materials\, research reproducibility\, and open science by archiving and distributing DNA-based research reagents and associated data to scientists worldwide.
URL:https://scienceinboston.com/event/building-better-covid-19-tools-together-using-scalable-ngs-to-accelerate-science-2/
LOCATION:MA
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2020/06/seqwell-webinar-social-01.jpg
END:VEVENT
END:VCALENDAR